載入...
Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents
The prognosis of patients with myelodysplastic syndromes (MDS) following failure of hypomethylating agent (HMA) therapy is poor. Allogeneic hematopoietic cell transplantation (HCT) can be effective in curing patients who have failed therapy with HMA. However, published results have not addressed the...
Na minha lista:
| 發表在: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481669/ https://ncbi.nlm.nih.gov/pubmed/28600031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.05.034 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|